Donald Trump receiving Covid-19 treatment yet to be peer-reviewed
President ’s doctor reveals treatment with experimental antibody cocktail REGN-COV2Coronavirus – latest updatesSee all our coronavirus coverageDonald Trump is being treated with an experimental antibody drug that has shown promising initial early results but has yet to be peer-reviewed. According to statement from his doctor, the president has received a single eight-gram dose of anantibody cocktail called REGN-COV2– a combination of two human neutralising antibodies against the virus.The treatment was developed by Regeneron Pharmaceuticals, which previously developed a similar antibody drug against Ebola. He is also taking zinc, vitamin D, melatonin, aspirin and the heartburn drug famotidine – often sold in the US under the brand name Pepcid. Although the drug has not been shown to work against coronavirus, researchers are studying it as a possible treatment.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Melissa Davey, Ian Sample and agencies Tags: Donald Trump Coronavirus outbreak US news Infectious diseases Microbiology Medical research Science Source Type: news
More News: American Health | Aspirin | Coronavirus | COVID-19 | Ebola | Famotidine | Heartburn | Infectious Diseases | Melatonin | Microbiology | Outbreaks | Research | Science | Trump | USA Health | Vitamin D | Vitamins | Zinc